Anna Alsborger appointed Head of Transactions at Hemfosa Fastigheter
Anna Alsborger has been recruited as Hemfosa’s new Head of Transactions. Anna Alsborger has extensive experience from similar positions at both listed and unlisted property companies and from transaction advisory services. She will take up her new position in September 2018 and will be joining Hemfosa’s Group management.
Anna Alsborger most recently held the position of Head of Transactions at Hemsö Fastighets AB, where she worked for eight years in various roles in transactions and strategy. She previously worked at Kungsleden for three years, including a position as project manager in transactions and analysis. Prior to this, Anna worked at Catella with transaction advisory services and at EY with property analysis and valuation. She was born in 1977 and holds a Master of Science in Engineering Surveying from the KTH Royal Institute of Technology in Stockholm.
“Together with the recruitment of Caroline Arehult, incoming CEO of Hemfosa, the recruitment of Anna Alsborger as Hemfosa’s new Head of Transactions is another strategically important recruitment that we are pleased to have accomplished. Anna has precisely the background and experience we sought now that Stina Lindh Hök has chosen to accept the position as COO, including responsibility for transactions at Nyfosa, in connection with the planned division of the Group into two listed companies,” says Bengt Kjell, Chairman of the Board of Hemfosa.
For further information, please contact:
Bengt Kjell, Chairman of the Board, mobile +46 70 594 53 98, office +46 8 448 04 80
About Hemfosa Fastigheter
Hemfosa is a Swedish property company focused on community service properties in the Nordic region, with the Swedish state and municipalities as its largest tenants. This provides stable revenue flows and a healthy yield. Hemfosa also aims to create value through active participation in the transaction market. As per March 31, 2018, Hemfosa owned properties with a total property value of approximately SEK 45 billion. The company’s ordinary share has been listed since March 2014, and the preference share since December 2014, both on Nasdaq Stockholm. Read more at www.hemfosa.se.